MedPath

Comparison of the effect of Ibuprofen, Naufafen, Mefenamic acid and Celecoxib on the improvement of dental pain in the stage before the endodontic emergencies

Not Applicable
Recruiting
Conditions
symptomatic pulpitis.
pulpitis
Registration Number
IRCT20171109037332N1
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

The patient has an irreversible acute pulpitis, diagnosed by a dentist; Lack of medical problem (20) (such as history of stroke or heart failure, heart failure, blood pressure, asthma, nasal polyps, liver or kidney disease, gastric ulcer, systemic lupus, blood clotting problems, etc.); Access to the patient; Patients without oral disease and history of corticosteroid susceptibility are nonsteroidal inflammation; The teeth should be permanent with closed apex; Failure to quickly deal with endodontic emergencies; Patient satisfaction and compliance form completion

Exclusion Criteria

Patients who have received a home for up to 6 hours before; Patients who for any reason prohibit the use of the drugs studied.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intensity of pain. Timepoint: Measure the severity of pain at the beginning of the study (before the intervention) and 1 hour after taking the drug. Method of measurement: Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath